Cargando…
Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
Prostacyclins are the mainstay treatment for patients with severe pulmonary arterial hypertension. This case highlights the transition from selexipag to oral treprostinil. Our patient improved both subjectively and objectively. Cardiac output and index, as measured by the echocardiogram, improved 12...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144673/ https://www.ncbi.nlm.nih.gov/pubmed/32292582 http://dx.doi.org/10.1177/2045894019898032 |